ATHENS – As COVID-19 picks up in a second wave after being held back by an early lockdown, Greek health officials have said the situation is critical but manageable, but preparations are underway to get more than 600,000 doses of a vaccine that is in clinical trials.
The tests were conducted and co-developed
Oxford Jenner Institute and UK pharmaceutical company AstraZeneca, with the world hoping to find a panacea against the deadly coronavirus which continues to spread.
The company plans to have a first batch of 30 million doses of the vaccine in November for the EU if it proves safe and effective in ongoing trials in a rush to find a response to COVID-19.
EU officials have said an additional 100 million vaccines could be available in a second development, with the Greek government saying a critical issue concerns the terms of compensating vaccine manufacturers for the cost of compensating patients in the event effects. unexpected guarantee.
Charalambos Gogos, an infectious disease specialist and member of Greece’s COVID-19 expert committee, said the second wave could be curbed with early diagnosis and effective treatment and surveillance, the document said.
But the New Democracy government, despite having imposed several health protocols, has still failed to get people to obey, the complacency and defiance that led to the resurgence of the Coronavirus.
Gogos said health officials recorded 841 cases of the imported virus out of a total of 6,320 new infections between early August and September 4, of which 30% were asymptomatic, while 66% came from contact with a case confirmed.